Cargando…

Enlarged adipocytes from subcutaneous vs. visceral adipose tissue differentially contribute to metabolic dysfunction and atherogenic risk of patients with obesity

Morphological characteristics and source of adipose tissue as well as adipokines may increase cardiometabolic risk. This study aimed to explore whether adipose tissue characteristics may impact metabolic and atherogenic risks. Subcutaneous Adipose Tissue (SAT), Visceral Adipose Tissue (VAT) and peri...

Descripción completa

Detalles Bibliográficos
Autores principales: Suárez-Cuenca, Juan Antonio, De La Peña-Sosa, Gustavo, De La Vega-Moreno, Karen, Banderas-Lares, Diana Zaineff, Salamanca-García, Moisés, Martínez-Hernández, José Enrique, Vera-Gómez, Eduardo, Hernández-Patricio, Alejandro, Zamora-Alemán, Carlos Ramiro, Domínguez-Pérez, Gabriela Alexandra, Ruíz-Hernández, Atzín Suá, Gutiérrez-Buendía, Juan Ariel, Melchor-López, Alberto, Ortíz-Fernández, Moisés, Montoya-Ramírez, Jesús, Gaytán-Fuentes, Omar Felipe, Toríz-Ortíz, Angélica, Osorio-Valero, Mario, Orozco-Vázquez, Julita, Alcaráz-Estrada, Sofía Lizeth, Rodríguez-Arellano, Martha Eunice, Maldonado-Arriaga, Brenda, Pérez-Cabeza de Vaca, Rebeca, Escamilla-Tilch, Mónica, Pineda-Juárez, Juan Antonio, Téllez-González, Mario Antonio, García, Silvia, Mondragón-Terán, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815822/
https://www.ncbi.nlm.nih.gov/pubmed/33469087
http://dx.doi.org/10.1038/s41598-021-81289-2
_version_ 1783638314673242112
author Suárez-Cuenca, Juan Antonio
De La Peña-Sosa, Gustavo
De La Vega-Moreno, Karen
Banderas-Lares, Diana Zaineff
Salamanca-García, Moisés
Martínez-Hernández, José Enrique
Vera-Gómez, Eduardo
Hernández-Patricio, Alejandro
Zamora-Alemán, Carlos Ramiro
Domínguez-Pérez, Gabriela Alexandra
Ruíz-Hernández, Atzín Suá
Gutiérrez-Buendía, Juan Ariel
Melchor-López, Alberto
Ortíz-Fernández, Moisés
Montoya-Ramírez, Jesús
Gaytán-Fuentes, Omar Felipe
Toríz-Ortíz, Angélica
Osorio-Valero, Mario
Orozco-Vázquez, Julita
Alcaráz-Estrada, Sofía Lizeth
Rodríguez-Arellano, Martha Eunice
Maldonado-Arriaga, Brenda
Pérez-Cabeza de Vaca, Rebeca
Escamilla-Tilch, Mónica
Pineda-Juárez, Juan Antonio
Téllez-González, Mario Antonio
García, Silvia
Mondragón-Terán, Paul
author_facet Suárez-Cuenca, Juan Antonio
De La Peña-Sosa, Gustavo
De La Vega-Moreno, Karen
Banderas-Lares, Diana Zaineff
Salamanca-García, Moisés
Martínez-Hernández, José Enrique
Vera-Gómez, Eduardo
Hernández-Patricio, Alejandro
Zamora-Alemán, Carlos Ramiro
Domínguez-Pérez, Gabriela Alexandra
Ruíz-Hernández, Atzín Suá
Gutiérrez-Buendía, Juan Ariel
Melchor-López, Alberto
Ortíz-Fernández, Moisés
Montoya-Ramírez, Jesús
Gaytán-Fuentes, Omar Felipe
Toríz-Ortíz, Angélica
Osorio-Valero, Mario
Orozco-Vázquez, Julita
Alcaráz-Estrada, Sofía Lizeth
Rodríguez-Arellano, Martha Eunice
Maldonado-Arriaga, Brenda
Pérez-Cabeza de Vaca, Rebeca
Escamilla-Tilch, Mónica
Pineda-Juárez, Juan Antonio
Téllez-González, Mario Antonio
García, Silvia
Mondragón-Terán, Paul
author_sort Suárez-Cuenca, Juan Antonio
collection PubMed
description Morphological characteristics and source of adipose tissue as well as adipokines may increase cardiometabolic risk. This study aimed to explore whether adipose tissue characteristics may impact metabolic and atherogenic risks. Subcutaneous Adipose Tissue (SAT), Visceral Adipose Tissue (VAT) and peripheral blood were obtained from obese patients submitted to bariatric surgery. Adipose tissue (morphometry), plasma adiponectin, TNF-α, resistin (multiplexing) and biochemical chemistry were analyzed; as well as endothelial dysfunction (Flow Mediated Dilation, FMD) and atherogenesis (Carotid Intima Media Thickness, CIMT). Subgroups divided by adipocyte size and source were compared; as well as correlation and multivariate analysis. Sixty patients 36.6% males, aged 44 years-old, BMI 46.7 kg/m(2) were included. SAT’s adipocytes showed a lower range of size expandability than VAT’s adipocytes. Independent from their source, larger adipocytes were associated with higher glucose, lower adiponectin and higher CIMT. Particularly, larger adipocytes from SAT were associated with higher blood pressure, lower insulin and HDL-cholesterol; and showed positive correlation with glucose, Hb(A1c), systolic/diastolic values, and negatively correlated with insulin and adiponectin. VAT’s larger adipocytes particularly associated with lower resistin and lower FMD values. Gender and Diabetes Mellitus significantly impacted the relation of adipocyte size/source with the metabolic and atherogenic risk. Multivariable analysis suggested hypertension-resistin-Hb(A1c) interactions associated with SAT’s larger adipocytes; whereas potential insulin-adiponectin associations were observed for VAT’s larger adipocytes. Adipocyte morphology and source are differentially related with cardiometabolic and atherogenic risk in population with obesity, which are potentially affected by gender and Diabetes Mellitus.
format Online
Article
Text
id pubmed-7815822
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-78158222021-01-21 Enlarged adipocytes from subcutaneous vs. visceral adipose tissue differentially contribute to metabolic dysfunction and atherogenic risk of patients with obesity Suárez-Cuenca, Juan Antonio De La Peña-Sosa, Gustavo De La Vega-Moreno, Karen Banderas-Lares, Diana Zaineff Salamanca-García, Moisés Martínez-Hernández, José Enrique Vera-Gómez, Eduardo Hernández-Patricio, Alejandro Zamora-Alemán, Carlos Ramiro Domínguez-Pérez, Gabriela Alexandra Ruíz-Hernández, Atzín Suá Gutiérrez-Buendía, Juan Ariel Melchor-López, Alberto Ortíz-Fernández, Moisés Montoya-Ramírez, Jesús Gaytán-Fuentes, Omar Felipe Toríz-Ortíz, Angélica Osorio-Valero, Mario Orozco-Vázquez, Julita Alcaráz-Estrada, Sofía Lizeth Rodríguez-Arellano, Martha Eunice Maldonado-Arriaga, Brenda Pérez-Cabeza de Vaca, Rebeca Escamilla-Tilch, Mónica Pineda-Juárez, Juan Antonio Téllez-González, Mario Antonio García, Silvia Mondragón-Terán, Paul Sci Rep Article Morphological characteristics and source of adipose tissue as well as adipokines may increase cardiometabolic risk. This study aimed to explore whether adipose tissue characteristics may impact metabolic and atherogenic risks. Subcutaneous Adipose Tissue (SAT), Visceral Adipose Tissue (VAT) and peripheral blood were obtained from obese patients submitted to bariatric surgery. Adipose tissue (morphometry), plasma adiponectin, TNF-α, resistin (multiplexing) and biochemical chemistry were analyzed; as well as endothelial dysfunction (Flow Mediated Dilation, FMD) and atherogenesis (Carotid Intima Media Thickness, CIMT). Subgroups divided by adipocyte size and source were compared; as well as correlation and multivariate analysis. Sixty patients 36.6% males, aged 44 years-old, BMI 46.7 kg/m(2) were included. SAT’s adipocytes showed a lower range of size expandability than VAT’s adipocytes. Independent from their source, larger adipocytes were associated with higher glucose, lower adiponectin and higher CIMT. Particularly, larger adipocytes from SAT were associated with higher blood pressure, lower insulin and HDL-cholesterol; and showed positive correlation with glucose, Hb(A1c), systolic/diastolic values, and negatively correlated with insulin and adiponectin. VAT’s larger adipocytes particularly associated with lower resistin and lower FMD values. Gender and Diabetes Mellitus significantly impacted the relation of adipocyte size/source with the metabolic and atherogenic risk. Multivariable analysis suggested hypertension-resistin-Hb(A1c) interactions associated with SAT’s larger adipocytes; whereas potential insulin-adiponectin associations were observed for VAT’s larger adipocytes. Adipocyte morphology and source are differentially related with cardiometabolic and atherogenic risk in population with obesity, which are potentially affected by gender and Diabetes Mellitus. Nature Publishing Group UK 2021-01-19 /pmc/articles/PMC7815822/ /pubmed/33469087 http://dx.doi.org/10.1038/s41598-021-81289-2 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Suárez-Cuenca, Juan Antonio
De La Peña-Sosa, Gustavo
De La Vega-Moreno, Karen
Banderas-Lares, Diana Zaineff
Salamanca-García, Moisés
Martínez-Hernández, José Enrique
Vera-Gómez, Eduardo
Hernández-Patricio, Alejandro
Zamora-Alemán, Carlos Ramiro
Domínguez-Pérez, Gabriela Alexandra
Ruíz-Hernández, Atzín Suá
Gutiérrez-Buendía, Juan Ariel
Melchor-López, Alberto
Ortíz-Fernández, Moisés
Montoya-Ramírez, Jesús
Gaytán-Fuentes, Omar Felipe
Toríz-Ortíz, Angélica
Osorio-Valero, Mario
Orozco-Vázquez, Julita
Alcaráz-Estrada, Sofía Lizeth
Rodríguez-Arellano, Martha Eunice
Maldonado-Arriaga, Brenda
Pérez-Cabeza de Vaca, Rebeca
Escamilla-Tilch, Mónica
Pineda-Juárez, Juan Antonio
Téllez-González, Mario Antonio
García, Silvia
Mondragón-Terán, Paul
Enlarged adipocytes from subcutaneous vs. visceral adipose tissue differentially contribute to metabolic dysfunction and atherogenic risk of patients with obesity
title Enlarged adipocytes from subcutaneous vs. visceral adipose tissue differentially contribute to metabolic dysfunction and atherogenic risk of patients with obesity
title_full Enlarged adipocytes from subcutaneous vs. visceral adipose tissue differentially contribute to metabolic dysfunction and atherogenic risk of patients with obesity
title_fullStr Enlarged adipocytes from subcutaneous vs. visceral adipose tissue differentially contribute to metabolic dysfunction and atherogenic risk of patients with obesity
title_full_unstemmed Enlarged adipocytes from subcutaneous vs. visceral adipose tissue differentially contribute to metabolic dysfunction and atherogenic risk of patients with obesity
title_short Enlarged adipocytes from subcutaneous vs. visceral adipose tissue differentially contribute to metabolic dysfunction and atherogenic risk of patients with obesity
title_sort enlarged adipocytes from subcutaneous vs. visceral adipose tissue differentially contribute to metabolic dysfunction and atherogenic risk of patients with obesity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815822/
https://www.ncbi.nlm.nih.gov/pubmed/33469087
http://dx.doi.org/10.1038/s41598-021-81289-2
work_keys_str_mv AT suarezcuencajuanantonio enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity
AT delapenasosagustavo enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity
AT delavegamorenokaren enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity
AT banderaslaresdianazaineff enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity
AT salamancagarciamoises enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity
AT martinezhernandezjoseenrique enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity
AT veragomezeduardo enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity
AT hernandezpatricioalejandro enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity
AT zamoraalemancarlosramiro enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity
AT dominguezperezgabrielaalexandra enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity
AT ruizhernandezatzinsua enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity
AT gutierrezbuendiajuanariel enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity
AT melchorlopezalberto enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity
AT ortizfernandezmoises enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity
AT montoyaramirezjesus enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity
AT gaytanfuentesomarfelipe enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity
AT torizortizangelica enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity
AT osoriovaleromario enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity
AT orozcovazquezjulita enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity
AT alcarazestradasofializeth enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity
AT rodriguezarellanomarthaeunice enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity
AT maldonadoarriagabrenda enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity
AT perezcabezadevacarebeca enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity
AT escamillatilchmonica enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity
AT pinedajuarezjuanantonio enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity
AT tellezgonzalezmarioantonio enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity
AT garciasilvia enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity
AT mondragonteranpaul enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity